SARS-COV-2
Clinical trials for SARS-COV-2 explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 trials appear
Sign up with your email to follow new studies for SARS-COV-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive study tracks 12,000 people for COVID vaccine side effects
⭐️ VACCINE ⭐️ OngoingThis study is monitoring the safety of the already-approved Pfizer COVID-19 vaccine in real-world use in Korea. It will follow 12,000 people who receive the vaccine as part of their normal healthcare, tracking any side effects they report for 28 days after each dose. The goal is …
Matched conditions: SARS-COV-2
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:43 UTC
-
Stem cells touted as repair system for COVID-19 damage
Disease control TerminatedThis study aimed to test a treatment for COVID-19 using special cells called pluripotent stem cells. The idea was that these cells could act as a repair system, replacing cells damaged by the virus. The study was withdrawn and did not enroll any participants.
Matched conditions: SARS-COV-2
Phase: PHASE2 • Sponsor: DHA Coffee Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Researchers planned to track Quarantine's mental toll on vulnerable patients
Knowledge-focused TerminatedThis study aimed to understand how COVID-19 quarantine affected the mental health of people already receiving psychiatric care. Researchers planned to measure symptoms of post-traumatic stress, depression, anxiety, and insomnia in patients during and after quarantine. The study w…
Matched conditions: SARS-COV-2
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Researchers probe heart risks after COVID shots
Knowledge-focused OngoingThis study aims to understand heart injury risks after COVID-19 vaccination. Researchers will use blood tests and heart scans to identify patients who might develop heart problems. The goal is to help doctors recognize at-risk patients earlier and determine who needs long-term mo…
Matched conditions: SARS-COV-2
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Hospital tracks Staff's COVID antibodies for a year after vaccine
Knowledge-focused OngoingThis study aims to understand how the immune system of hospital employees responds to the AstraZeneca COVID-19 vaccine over time. Researchers will measure antibody levels in 200 vaccinated staff members at 6 weeks, 6 months, and 12 months after their second dose. The goal is to g…
Matched conditions: SARS-COV-2
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Pfizer digs into data: can its vaccine stop long COVID?
Knowledge-focused OngoingThis study uses existing health insurance and state vaccination records to answer two questions. First, it checks if the Pfizer-BioNTech COVID-19 vaccine helps prevent Long COVID symptoms that can last for months after infection. Second, it looks at the characteristics of people …
Matched conditions: SARS-COV-2
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC